Literature DB >> 32946775

Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.

Rui Dong1, Ran Yang2, Yong Zhan2, Hua-Dong Lai3, Chun-Jing Ye2, Xiao-Ying Yao4, Wen-Qin Luo5, Xiao-Mu Cheng3, Ju-Ju Miao3, Jun-Feng Wang2, Bai-Hui Liu2, Xiang-Qi Liu2, Lu-Lu Xie2, Yi Li2, Man Zhang3, Lian Chen6, Wei-Chen Song7, Wei Qian3, Wei-Qiang Gao8, Yun-Hui Tang4, Chun-Yan Shen4, Wei Jiang9, Gong Chen2, Wei Yao2, Kui-Ran Dong2, Xian-Min Xiao2, Shan Zheng2, Kai Li10, Jia Wang11.   

Abstract

Neuroblastoma (NB), which is a subtype of neural-crest-derived malignancy, is the most common extracranial solid tumor occurring in childhood. Despite extensive research, the underlying developmental origin of NB remains unclear. Using single-cell RNA sequencing, we generate transcriptomes of adrenal NB from 160,910 cells of 16 patients and transcriptomes of putative developmental cells of origin of NB from 12,103 cells of early human embryos and fetal adrenal glands at relatively late development stages. We find that most adrenal NB tumor cells transcriptionally mirror noradrenergic chromaffin cells. Malignant states also recapitulate the proliferation/differentiation status of chromaffin cells in the process of normal development. Our findings provide insight into developmental trajectories and cellular states underlying human initiation and progression of NB.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Schwann cell precursors; cell differentiation; cell proliferation; cells of origin; chromaffin cells; neural crest cells; neuroblastoma; pediatric cancer; single-cell RNA sequencing; tumor heterogeneity

Mesh:

Year:  2020        PMID: 32946775     DOI: 10.1016/j.ccell.2020.08.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  35 in total

1.  Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1.

Authors:  Nathaniel W Mabe; Min Huang; Guillermo N Dalton; Gabriela Alexe; Daniel A Schaefer; Anna C Geraghty; Amanda L Robichaud; Amy S Conway; Delan Khalid; Marius M Mader; Julia A Belk; Kenneth N Ross; Michal Sheffer; Miles H Linde; Nghi Ly; Winnie Yao; Maria Caterina Rotiroti; Benjamin A H Smith; Marius Wernig; Carolyn R Bertozzi; Michelle Monje; Constantine S Mitsiades; Ravindra Majeti; Ansuman T Satpathy; Kimberly Stegmaier; Robbie G Majzner
Journal:  Nat Cancer       Date:  2022-07-11

2.  Single-cell sequencing reveals activation of core transcription factors in PRC2-deficient malignant peripheral nerve sheath tumor.

Authors:  Xiyuan Zhang; Hannah E Lou; Vishaka Gopalan; Zhihui Liu; Hilda M Jafarah; Haiyan Lei; Paige Jones; Carly M Sayers; Marielle E Yohe; Prashant Chittiboina; Brigitte C Widemann; Carol J Thiele; Michael C Kelly; Sridhar Hannenhalli; Jack F Shern
Journal:  Cell Rep       Date:  2022-09-20       Impact factor: 9.995

3.  Serotonin limits generation of chromaffin cells during adrenal organ development.

Authors:  Polina Kameneva; Victoria I Melnikova; Maria Eleni Kastriti; Anastasia Kurtova; Emil Kryukov; Aliia Murtazina; Louis Faure; Irina Poverennaya; Artem V Artemov; Tatiana S Kalinina; Nikita V Kudryashov; Michael Bader; Jan Skoda; Petr Chlapek; Lucie Curylova; Lukas Sourada; Jakub Neradil; Marketa Tesarova; Massimo Pasqualetti; Patricia Gaspar; Vasily D Yakushov; Boris I Sheftel; Tomas Zikmund; Jozef Kaiser; Kaj Fried; Natalia Alenina; Elena E Voronezhskaya; Igor Adameyko
Journal:  Nat Commun       Date:  2022-05-25       Impact factor: 17.694

Review 4.  Advancing therapy for neuroblastoma.

Authors:  Bo Qiu; Katherine K Matthay
Journal:  Nat Rev Clin Oncol       Date:  2022-05-25       Impact factor: 65.011

5.  BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells.

Authors:  Jessica Sriha; Caroline Louis-Brennetot; Cécile Pierre-Eugène; Sylvain Baulande; Virginie Raynal; Amira Kramdi; Igor Adameyko; Uwe Ernsberger; Thomas Deller; Olivier Delattre; Isabelle Janoueix-Lerosey; Hermann Rohrer
Journal:  Cancers (Basel)       Date:  2022-06-01       Impact factor: 6.575

6.  Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.

Authors:  Selina Jansky; Ashwini Kumar Sharma; Verena Körber; Andrés Quintero; Umut H Toprak; Elisa M Wecht; Moritz Gartlgruber; Alessandro Greco; Elad Chomsky; Thomas G P Grünewald; Kai-Oliver Henrich; Amos Tanay; Carl Herrmann; Thomas Höfer; Frank Westermann
Journal:  Nat Genet       Date:  2021-03-25       Impact factor: 38.330

7.  Downregulation of fibronectin 1 attenuates ATRA-induced inhibition of cell migration and invasion in neuroblastoma cells.

Authors:  Xiaolin Tan; Wei Gong; Bo Chen; Baocheng Gong; Zhongyan Hua; Simeng Zhang; Yang Chen; Qi Li; Zhijie Li
Journal:  Mol Cell Biochem       Date:  2021-05-22       Impact factor: 3.396

Review 8.  Decoding Cancer Biology One Cell at a Time.

Authors:  Itay Tirosh; Mario L Suvà; L Nicolas Gonzalez Castro
Journal:  Cancer Discov       Date:  2021-04       Impact factor: 38.272

Review 9.  Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies.

Authors:  Kristina Ihrmark Lundberg; Diana Treis; John Inge Johnsen
Journal:  Curr Oncol Rep       Date:  2022-04-01       Impact factor: 5.945

Review 10.  Bone Marrow Environment in Metastatic Neuroblastoma.

Authors:  Chiara Brignole; Fabio Pastorino; Patrizia Perri; Loredana Amoroso; Veronica Bensa; Enzo Calarco; Mirco Ponzoni; Maria Valeria Corrias
Journal:  Cancers (Basel)       Date:  2021-05-19       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.